Ten UBC researchers are to receive funding from Michael Smith Foundation for Health Research's inaugural Innovation to Commercialization (I2C) competition.
The Innovation to Commercialization (I2C) Program is designed to help researchers advance discoveries or inventions towards commercialization by supporting commercialization activities that strengthen the value of their intellectual property, facilitate collaboration and attract future investment.
See MSFHR announcement | Full list of i2C award recipients
UBC Funding Recipients
Du, Caigan
Development of a novel organ preservation solution in transplantation
Research Location: Vancouver Prostate Centre / VCHRI
Ghahary, Aziz
Liquid skin substitute accelerates burn and non-healing wounds
Research Location: ICORD / VCHRI
Granville, David
A novel therapeutic for inflammatory skin diseases
Research Location: ICORD / VCHRI
Krassioukov, Andrei
Servo-controlled device to maintain physiological functioning
Co-funded with International Collaboration on Repair Discoveries (ICORD)
Research Location: ICORD / VCHRI
Kwon, Brian
Near infrared spectroscopy for the hemodynamic monitoring of acute spinal cord injury
Research Location: ICORD / VCHRI
Lester, Richard
Smart Text Analytic Tools (STAT) for analysis of patient-centred communications to strengthen health systems in BC
Research Location: VCHRI
MacAulay, Calum
Genomic Organization At Large (GOALS) predicts aggressive biological behaviour in prostate and breast cancers
Research Location: BC Cancer Agency
Minchinton, Andrew
DNA-PK inhibitors for use in combination with radiation therapy
Research Location: BC Cancer Agency
Ong, Christopher
Development of a novel biotherapeutic fusion protein inhibitor for treatment of advanced prostate cancer
Research Location: Vancouver Prostate Centre / VCHRI
Roberge, Michel
Preclinical evaluation of gentamicin B1 as treatment for inherited skin fragility disorders caused by nonsense mutations
Research Location: Life Sciences Institute